首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1917729

神經復健市場－2026年至2031年預測

Neurorehabilitation Market - Forecast from 2026 to 2031

出版日期: 2026年01月05日 | 出版商:

Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計神經復健市場將從 2025 年的 18.57 億美元成長到 2031 年的 36.79 億美元，複合年成長率為 12.07%。

神經復健市場呈現持續成長的態勢，其主要驅動力是臨床上迫切需要幫助神經病變患者恢復功能並改善生活品質。人口結構變化、技術創新和不斷發展的護理模式的協同效應，進一步推動了這一成長。包括中風、脊髓損傷、帕金森氏症和多發性硬化症在內的神經系統疾病在全球範圍內的發病率不斷上升，加上人口老化，導致需要高級復健護理的患者群體持續擴大。同時，技術突破正在改變治療模式，使其不再局限於輔助器具，而是積極促進神經可塑性和復原。

關鍵市場促進因素與技術趨勢

市場的主要促進因素是根本性的且相互關聯的。人口老化趨勢是主要催化劑。人口老化與慢性神經系統疾病和神經退化性疾病發病率的上升密切相關，從而持續催生了對用於解決運動障礙、認知衰退和維持獨立生活的設備的需求。同時，全球醫療保健基礎設施的擴張和專業化，特別是專業復健中心的建立，也促進了這項需求。這些機構需要各種先進設備來提供全面、多學科的照護。

最具活力的成長要素是技術的融合，因為市場透過多種先進模式的整合而不斷發展。

機器人和外骨骼：機器人步態訓練器和上肢外骨骼等設備可以提供頻繁、重複和生理上精確的運動療法，從而減輕治療師的工作量並實現強化訓練。
腦機介面（BCI）：BCI 在大腦和外部設備之間建立直接通訊通道，為功能恢復提供了可能，並描述了一種激活神經迴路的新型生物回饋療法機制。
非侵入性神經刺激：經顱磁刺激 (TMS) 和經顱直流電刺激 (tDCS) 等技術用於調節皮質興奮性和促進神經可塑性，通常與物理治療結合使用。
穿戴式感測器和遊戲化：穿戴式裝置能夠持續監測臨床環境以外的運動和進展，而遊戲化的復健系統透過互動練習提高患者的參與度和留存率。

這些技術的通用關鍵趨勢是人工智慧 (AI) 與數據分析的融合。 AI 演算法分析來自設備感測器的大量資料集，即時個人化治療通訊協定，預測復健軌跡，並為臨床醫生提供可操作的見解。這種向數據驅動的精準康復的轉變正在提高治療效果並最佳化治療結果。

市場區隔與競爭格局

市場已按設備類型、最終用戶和地區進行細分。主要產品類型包括神經機器人系統、腦機介面、穿戴式裝置、非侵入式刺激裝置和神經復健遊戲系統。最終用戶包括醫院、門診診所、專業復健中心以及日益成長的居家照護領域，這凸顯了對方便用戶使用、便攜且適用於遠端監控和遠距遠端醫療整合的設備的需求。

競爭格局的特點是既有成熟的醫療技術領導企業，也有專注於特定領域的創新公司。像雅培這樣的主要企業憑藉其在神經調控領域的深厚專業知識，提供用於治療慢性疼痛和運動障礙等疾病的植入式和體外神經刺激設備。像Bioness Inc.這樣的專業公司則專注於用於肢體復健的穿戴式功能性電刺激（FES）系統，而像Ekso Bionics Holdings, Inc.這樣的先驅企業則處於步態訓練用機器人外骨骼技術的前沿。這些公司在臨床證據、技術水平、整合能力以及成功獲得醫療保險報銷等方面展開競爭。

地理視角和區域優勢

北美在全球市場保持主導地位。這項優勢源自於多項結構性優勢：成熟且先進的醫療保健基礎設施，非常適合高成本技術的應用；大規模的老齡人口中神經系統疾病的高發生率；以及複雜但歷來支持醫療設備創新的監管和報銷環境。此外，該地區還聚集了許多大型醫療設備製造商、研究機構和創業投資，從而建構了一個強大的研發和商業化生態系統。

未來發展及策略意義

神經復健市場預計將持續發展壯大。不可逆轉的人口趨勢和神經系統疾病盛行率的不斷上升，確保了市場規模的持續成長。未來，人工智慧的深度整合、遠距復健平台的廣泛應用以及更經濟實惠、以消費者為中心的家用設備的開發，將共同塑造市場格局。產業相關人員的成功不僅取決於技術優勢，還取決於能否在改善功能性結果、成本效益以及與不斷發展的護理路徑無縫銜接等方面展現出明確的價值。隨著人們越來越關注以患者為中心的長期療效，這些設備將鞏固其作為功能復健過程中不可或缺的工具的地位，並將神經復健轉變為一個更可衡量、更個性化、更易於獲取的領域。

本報告的主要優勢

深入分析：獲取主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直細分市場和其他子細分市場。
競爭格局：了解全球主要參與企業的策略舉措，並了解透過正確的策略進入市場的潛力。
市場促進因素與未來趨勢：探索推動市場的動態因素和關鍵趨勢，以及它們將如何塑造未來的市場發展。
可操作的建議：利用這些見解，在快速變化的環境中製定策略決策，發展新的商業機會和收入來源。
受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

以下是一些公司如何使用這份報告的範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

2021-2025年實際數據，2026-2031年預測數據
成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
競爭定位、策略和市場佔有率分析
按業務板塊和地區（包括國家）分類的收入和預測評估
公司概況（策略、產品、財務資訊、重大發展等）

The neurorehabilitation devices market is characterized by sustained growth, driven by a critical clinical imperative: enhancing functional recovery and quality of life for individuals with neurological impairments. This expansion is underpinned by a confluence of demographic shifts, technological innovation, and evolving care models. The rising global prevalence of neurological disorders-including stroke, spinal cord injury, Parkinson's disease, and multiple sclerosis-coupled with an ageing population, establishes a persistent and growing patient base requiring advanced rehabilitative care. Concurrently, technological breakthroughs are transforming therapeutic paradigms, moving beyond supportive aids to become active facilitators of neuroplasticity and recovery.

Primary Market Drivers and Technological Trends

Key drivers propelling the market forward are foundational and interrelated. The demographic trend of population ageing is a primary catalyst, as advanced age correlates with a higher incidence of chronic neurological conditions and neurodegenerative diseases. This creates sustained demand for devices that address motor deficits, cognitive decline, and the preservation of independence. Complementing this demand is the global expansion and specialization of healthcare infrastructure, particularly the establishment of dedicated rehabilitation centers. These facilities necessitate a diverse array of sophisticated equipment to deliver comprehensive, multidisciplinary care.

The most dynamic growth vector is technological convergence. The market is evolving through the integration of several advanced modalities:

Robotics and Exoskeletons: Devices such as robotic gait trainers and upper-limb exoskeletons provide high-dosage, repetitive, and physiologically accurate movement therapy, reducing therapist burden and enabling intensive training.
Brain-Computer Interfaces (BCIs): BCIs create direct communication pathways between the brain and external devices, offering promising avenues for restoring function and providing novel biofeedback mechanisms to engage neural circuits.
Non-Invasive Neurostimulation: Techniques including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are used to modulate cortical excitability and promote neuroplasticity, often in conjunction with physical therapy.
Wearable Sensors and Gamification: Wearables enable continuous monitoring of movement and progress outside clinical settings, while gamified rehabilitation systems improve patient engagement and adherence through interactive exercises.

A pivotal trend across these technologies is the integration of Artificial Intelligence (AI) and Data Analytics. AI algorithms can analyze vast datasets from device sensors to personalize therapy protocols in real-time, predict recovery trajectories, and provide clinicians with actionable insights. This shift towards data-driven, precision rehabilitation is enhancing treatment efficacy and optimizing therapeutic outcomes.

Market Segmentation and Competitive Landscape

The market is segmented by device type, end-user, and geography. Key product categories include neurorobotic systems, brain-computer interfaces, wearable devices, non-invasive stimulators, and neurorehabilitation gaming systems. End-users span hospitals, outpatient clinics, specialized rehabilitation centers, and a growing home-care segment, which emphasizes the need for devices that are user-friendly, portable, and suitable for remote monitoring and telehealth integration.

The competitive landscape features established medical technology leaders and specialized innovators. Major players like Abbott Laboratories leverage deep expertise in neuromodulation, offering implantable and external neurostimulators for conditions such as chronic pain and movement disorders. Specialized firms such as Bioness Inc. focus on wearable functional electrical stimulation (FES) systems for limb rehabilitation, while pioneers like Ekso Bionics Holdings, Inc. are at the forefront of robotic exoskeleton technology for gait training. These companies compete on clinical evidence, technological sophistication, integration capabilities, and success in navigating reimbursement pathways.

Geographical Outlook and Regional Dominance

North America maintains a dominant position in the global market. This leadership is attributed to several structural advantages: a mature and advanced healthcare infrastructure conducive to adopting high-cost technologies, a high prevalence of neurological disorders within a sizeable ageing population, and a regulatory and reimbursement environment that, while complex, has historically supported innovation in medical devices. Furthermore, the region's concentration of leading device manufacturers, research institutions, and venture capital fosters a robust ecosystem for development and commercialization.

Future Trajectory and Strategic Implications

The neurorehabilitation devices market is poised for continued evolution and growth. The irreversible demographic trends and increasing burden of neurological disorders ensure a durable addressable market. The future will be shaped by the deeper integration of AI, the proliferation of telerehabilitation platforms, and the development of more affordable, consumer-centric devices for home use. Success for industry participants will increasingly depend on demonstrating not only technical superiority but also clear value in improving functional outcomes, cost-effectiveness, and seamless integration into evolving care pathways. As the focus on long-term patient-centric outcomes intensifies, these devices will solidify their role as indispensable tools in the journey toward functional recovery, transforming neurorehabilitation into a more measurable, personalized, and accessible discipline.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Neurorehabilitation Devices Market Segmentation

By Type
Neurorobotic Systems
Brain-Computer Interfaces
Wearable Devices
Non-Invasive Stimulators
Neurorehabilitation Gaming Systems
Others
By Application
Stroke
Spinal Cord Injury
Traumatic Brain Injury
Parkinson's Disease
Cerebral Palsy
Others
By End-User
Hospitals
Clinics
Rehabilitation Centers
Home Care Settings
By Geography
North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEUROREHABILITATION MARKET BY PRODUCT

5.1. Introduction
5.2. Neuro-Robotic System
5.3. Wearable Devices
5.4. Brain Computer Interface
5.5. Non-Invasive Stimulators
5.6. Neuronal Prosthetics
5.7. Others

6. NEUROREHABILITATION MARKET BY APPLICATION

6.1. Introduction
6.2. Stroke
6.3. Traumatic Brain Injury (TBI)
6.4. Spinal Cord Injury (SCI)
6.5. Parkinson's Disease
6.6. Cerebral Palsy
6.7. Others

7. NEUROREHABILITATION MARKET BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Clinics
7.4. Rehabilitation Centers
7.5. Home Care Settings

8. NEUROREHABILITATION MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others